SCM
TNXP icon

Sterling Capital Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Sterling Capital Management’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.75K Sell
294
-156
-35% -$2.01K ﹤0.01% 2767
2026
Q1 		$6.19K Sell
450
-284
-39% -$4.37K ﹤0.01% 2628
2025
Q4 		$11.5K Buy
734
+123
+20% +$2.27K ﹤0.01% 2539
2025
Q3 		$14.8K Buy
611
+407
+200% +$15.1K ﹤0.01% 2290
2025
Q2 		$7.34K Buy
+204
New +$5.34K ﹤0.01% 2303

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Sterling Capital Management's TNXP Position: Q2 2026 in Review

Sterling Capital Management reduced its Tonix Pharmaceuticals (TNXP) stake by 35% in Q2 2026, selling an estimated $2.01K and leaving 294 shares worth $3.75K. The position accounts for ﹤0.01% of the portfolio, ranked #2767.

Sterling Capital Management first reported a position in TNXP in Q2 2025 and has held it in 5 quarters since. The position peaked at $14.8K in Q3 2025. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Sterling Capital Management held 294 shares of Tonix Pharmaceuticals worth $3.75K as of Q2 2026.
  • Sterling Capital Management sold 156 Tonix Pharmaceuticals shares in Q2 2026, an estimated $2.01K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2767 holding.
  • Sterling Capital Management first reported a position in Tonix Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Sterling Capital Management's Tonix Pharmaceuticals position peaked at $14.8K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.